Trials / Completed
CompletedNCT02915978
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- INSYS Therapeutics Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl | Fentanyl delivered via sublingual spray |
| DRUG | Placebo | Matching placebo delivered via sublingual spray |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-02-10
- Completion
- 2017-02-10
- First posted
- 2016-09-27
- Last updated
- 2018-02-14
- Results posted
- 2018-02-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02915978. Inclusion in this directory is not an endorsement.